Rejuvenation Technologies Inc.

Company Overview

Rejuvenation Technologies Inc., located in Mountain View, CA, focuses on extending the human health span through cutting-edge therapeutics. Specializing in TERT mRNA-based therapies, the company aims to reverse over a decade of telomere shortening within a matter of days. It operates in the healthcare industry, specifically within therapeutics, and is a part of the Y Combinator S18 batch. With a small team size of two, Rejuvenation Technologies is at an early stage of its development.

Technologies and Therapeutic Approaches

Rejuvenation Technologies develops highly efficient telomere extension and synergistic regenerative therapeutics. The central technology involves telomerase mRNA encapsulated in nanoparticles to facilitate cellular uptake. One dose of this therapy can reverse years of telomere shortening in mere hours. The company's innovative approaches were invented by its founders at Stanford University, marking significant advancement in the field of gene therapy and nanomedicine.

Research and Development Pipeline

Rejuvenation Technologies has a comprehensive pipeline that includes a targeted lung program. This program is moving through detailed stages of development, reflecting the company's commitment to advancing telomere-extension therapies to the clinic. The R&D efforts are aligned with their mission to combat aging by focusing on reversing telomere shortening, a key factor associated with the aging process.

Locations and Services

Headquartered in Mountain View, CA, Rejuvenation Technologies operates primarily within the United States and Canada. The company supports a range of service models including remote and partly remote configurations. This flexibility ensures engagement with a wider demographic, accommodating various needs for both employment and service offerings.

Y Combinator and Market Presence

Rejuvenation Technologies was part of the Y Combinator S18 batch, a significant milestone that highlights its credibility and potential for growth. The company's market presence spans across the United States and Canada, emphasizing its focus on pioneering anti-aging and gene therapy solutions. Tags associated with the company include Anti-Aging, Gene Therapy, and Nanomedicine, indicating its specialized focus within the therapeutics sub-industry.

Report inaccurate information

Companies similar to Rejuvenation Technologies Inc.

Cisterna Biologics, based in San Diego, California, specializes in developing mRNA-based therapeutics, focusing on improving quality, quantity, longevity, and cost.

3T Biosciences develops next-generation therapies for solid tumors and immune-mediated diseases using proprietary technology and machine learning, based in South San Francisco.

Dorian Therapeutics, based in San Carlos, CA, is a biotech company specializing in developing therapeutics aimed at rejuvenating tissues and treating age-related diseases.

Output Biosciences, formerly known as Jingu Health, is a New York-based healthcare company focused on extending human healthspan by developing preventative therapies using computational biology and AI.

Gerostate Alpha, based in Novato, CA, is a healthcare company focused on developing innovative therapeutics to address aging and chronic diseases.

Engage Bio, based in Santa Clara, CA, is a biotech startup in the healthcare industry focusing on developing mRNA-based immunotherapies for cancer treatment.

Geron is a biopharmaceutical company focused on developing treatments for blood cancers through telomerase inhibition, with its lead product candidate, imetelstat, currently in Phase 3 clinical trials.

Helix Nanotechnologies, based in Boston and Cambridge, MA, specializes in mRNA technology to enhance drug discovery and delivery, aiming to make biological treatments more accessible and efficient.

Serna Bio, formerly Ladder Therapeutics (LTX), is a biotech company specializing in the development of novel therapeutics targeting the transcriptome for diseases with high unmet medical needs.

Serinus Biosciences, based in New York, NY, is a biotech company focused on developing combination therapies to combat cancer treatment resistance, utilizing an AI platform informed by system biology.